Cellular, molecular and biochemical differences in the pathophysiology of healing between acute wounds, chronic wounds and wounds in the aged

World Wide Wounds

Volumn 2005, Issue , 2004, Pages

  Enoch, Stuart ^a   Price, Patricia ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Acute wounds; Ageing; Assessment; Chronic wounds; Outcome measures; Pathophysiology of healing; Wound infection

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; CATHEPSIN G; COLLAGENASE 3; CYTOKINE; FIBRONECTIN; FREE RADICAL; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LEUKOCYTE ELASTASE; NEUTROPHIL COLLAGENASE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE; SERINE PROTEINASE; STEROID; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE; VITRONECTIN;

ACUTE DISEASE; AGING; CELL MIGRATION; CELL POPULATION; CHEMICAL ANALYSIS; CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; TISSUE REPAIR; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

EID: 27644530966     PISSN: 13692607     EISSN: 13692607     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed) 1985; 290(6485): 1855-56.
2. Nelzén O, Bergqvist D, Lindhagen A, Hallbook T. Chronic leg ulcers; an understimated problem in primary health care among elderly patients. J Epidemiol Community Health 1991; 45: 184-87.
3. Nelzén O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been understimated: results of a validated population questionnaire. Br J Surg 1996; 83(2): 255-58.
4. Callam MJ, Harper DR, Dale JJ, Ruckley CV. Chronic ulcer of the leg: clinical history. Br Med J (Clin Res Ed): 294(6584): 1389-91
5. Clark RAF. Wound repair: overview and general considerations. In: The Molecular and Cellular Biology of Wound Reapair. Clark RAF, editor. London: Plenum Press, 1996; 3-50.
6. Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79(5): 264-69.
7. Grinnell F, Billingham RE, Burgess L. Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 1981; 76(3): 181-89.
8. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78(1): 71-100.
9. Slavin J. The role of cytokines in wound healing. J Pathol 1996; 178(1): 5-10.
10. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994; 124(4):401-04.
11. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 5(1): 40-06.
12. Lauer G, Sollberg S, Cole M, Flamme I, Stürzebecher J, Mann K, Krieg T, Eming SA. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2006; 115(1): 12-18.
13. Kurkinen M, Vaheri A, Roberts PJ, Stenman S. Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest 1980; 43(1): 47-51.
14. Clark RA. Wound repair. Curr Opin Cell Biol 1989; 1(5): 100-08.
15. Clark RAF. Mechanisms of cutaneous wound repair. Volume 1. In: Dermatology in General Medicine. Fitzpatrick TB, Eisen AZ, Wolff K et al, editors. New York: McGraw-Hill, 1993; 473-86.
16. Winter GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-94.
17. Clark RA, Nielsen LD, Welch MP, McPherson JM. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblast to TGF-beta. J Cell Sci 1995; 108((Pt 3)): 1251-61
18. Welch MP, Odland GF, Clark RA. Temporal relationships of F-actin bundle formation, collagen nd fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 1990; 110(1): 133-45.
19. Levenson SM, Geever EF, Crowley LV, Oates JF, Berard CW Rosen H. The healing of rat skin wounds. Ann Surg 1965; 161: 293-308.
20. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146(1): 56-66.
21. Jürgensmeier JM, Schmitt CP, Viesel E, Höfler P, Bauer G. Transforming growth factor beta-treated normal fibroblast eliminate transformed fibroblasts by induction of apoptosis. Cancer Res 1994; 54(2): 393-98.
22. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro UE, Rodeheaver G, Robson MC. Definitions and guidelines for assesment of wounds and evaluation of healing. Arch Dermatol 1994, 130(4): 489-93.
23. Yager DR. Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wounds fluid from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107(5): 743-48.
24. Schultz GS, Mast BA. Molecular analysis of the environment of healing and chronic wounds: cytokines, protease and growth factors. Wounds 1998; 10((Suppl F)): 1F-9F.
25. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 2000; 115(5): 225-33.
26. Grinnell F, Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alphal-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 1996; 106(2): 335-41.
27. Wlaschek M, Peus D, Achterberg V, Meyer-Ingold W, Scharffetter-Kochanek K. Protease inhibitors protect growth factor activity in chronic wounds. Br J Dermatol 1997; 137(4): 646.
28. Harris IR, Yee KC, Walters CE, Cunliffe WJ, Kearney JN, Wood EJ, Ingham E. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. Exp Dermatol 1995; 4(6): 342-49.
29. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and chronic leg ulcers. Wound Repair Regen 2000; 8(1): 13-25.
30. Mendez MV, Raffetto JD, Phillips T, Menzoian JO, Park HY. The proliferative capacity of neonatal skin fibroblast is reduced after exposure to venous ulcer wound fluid: A potential mechanism for senescence in venous ulcers. J Vasc Surg 1999; 30(4): 734-43.
31. Whiston RJ, Hallett MB, Davies EV, Harding KG, Lane IF. Inappropriate neutrophil activation in venous disease. Br J Surg 1994; 81(5): 695-98.
32. Moore K, Ruge F, Harding KG. T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers. Br J Dermatol 1997; 137(2): 188-94.
33. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998; 111(5): 850-57.
34. Stanley AC, Park HY, Phillips TJ, Russakovsky V, Menzoian JO. Reduced growth of dermal fibroblast from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg 1997; 26(6): 994-99; discusion 999-1001.
35. Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitrogenic response to PDGF-BB of fibroblast isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999; 112(4): 463-69.
36. Mendez MV, Stanley A, Phillips T, Murphy M, Menzoian JO, Park HY. Fibroblasts cultured from distal lower extremities in patiens with venous reflux display cellular characteristics of senescence. J Vasc Surg 1998; 28(6): 1040-50.
37. Vande Berg JS, Rudolph R, Hollan C, Haywood-Reid PL. Fibroblast senescence in pressure ulcers. Wound Repair Regen 1998; 6(1): 38-49.
38. Adair HM. Epidermal repair in chronic venous ulcers. Br J Surg 1977; 64(11): 800-04.
39. Andriessen MP, van Bergen BH, Spruijt KI, Go IH, Schalkwijk J, van de Kerkhof PC. Epidermal proliferation is not impared in chronic venous ulcers. Acta Derm Venereol 1995; 75(6): 459-62.
40. Agren MS, Eaglstein WH, Ferguson MW, et al. Causes and effect of chronic information in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) 2000; 210: 3-17.
41. Bucalo B, Eagistein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen 1993; 1(3): 181-86.
42. Raffetto JD, Mendez MV, Marien BJ, Byers HR, Phillips TJ, Park HY, Menzoian JO. Changes in cellular motility and cystokeletal actin in fibroblasts from patiens with chronic venous insufficeincy and in neonatal fibroblasts in the presence of chronic wound fluid. J Vasc Surg 2001; 33(6): 1233-41.
43. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Fergusion MW. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992; 141(5): 1085-95.
44. Herrick SE, Ireland GW, Simon D, McCollum CN, Ferguson MW. Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. J Invest Dermatol 1996; 106(1): 187-93.
45. Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badiavas E, Palanga V. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta I. J Dermatol Sci 1997; 16(1): 59-66.
46. Salim AS. The role of oxygen-derived free radicals in the managament of venous (varicose) ulceration: a new approach. World J Surg 1991; 15(2): 264-69.
47. Abd-El-Aleem SA, Ferguson MW, Appleton I, Kairsingh S, Jude EB, Jones K, McColhum CN, Ireland GW. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol 2000; 191(4): 434-42.
48. Howlader MH, Smith PD. Increased plasma total nitric oxide among patients with severe chronic venous disease. Int Angiol 2002; 21(2): 180-86.
49. Jude EB, Tentolouris N, Appleton I, Anderson S, Boulton AJ. Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers. Wound Repair Regen 2001; 9(5): 353-59.
50. Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and effeciency of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 1998; 39(5 Pt 1): 737-40.
51. Baharestani M. The clinical relevance of debridement. In: The clinical relevance of debridement. Baharestani M, Gottrup F, Holstein P, Vanscheidt W, editors. Heidelberg: Springer-Verlag, 1999; 1-13
52. Davey ME, O'toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000; 64(4): 847-67.
53. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz G. Ratios of activated matrix metalloprotien-9 to tisue inhibitor of matrix metalloproteinase-1 in wound fluids are inverse correlated with healing of pressure ulcers. Wound Repair Regen 2002; 10(1): 26-37.
54. Grove GL, Kligman AM. Age-associated changes in human epidermal cell renewal. J Gerontol 1983; 38(2): 137-42.
55. Kurban RS, Bhawan J. Histologic changes in skin associated with aging. J Dermatol Surg Oncol 1990; 16(10): 908-14.
56. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93(6): 639-43.
57. Holt DR, Kirk SJ, Regan MC, Hurson M, Lindblad WJ, Barbul A. Effect of age on wound healing in healthy human beings. Surgery 1992; 112(2): 293-97; discussion 297-8.
58. Gilchrest BA. In vitro assessment of keratinocyte aging. J Investment Dermatol 1983; 81(1 Suppl): 184s-9s
59. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92(20): 9363-67
60. Kondo H, Yonezawa Y. Changes in the migratory ability of human lung and skin fibroblasts during in vitro and in vivo cellular senescence. Mech Ageing Dev 1992; 63(3): 223-33.
61. Muggleton-Harris AL, Reisert PS, Burghoff RL. In vitro charactization of response to stimulus (wounding) with regard to aging in human skin fibroblasts. Mech Ageing Dev 1982; 19(1): 37-43.
62. Ashcroft GS, Horan MA, Ferguson MW. The effects of ageing on cutaneous wound healing in mammals. J. Anat 1995; 187((Pt 1)): 1-26.
63. Shevitz J, Jenkins CS, Hatcher VB. Fibronectin synthesis and degradation in human fibroblasts with aging. Mech Aging Dev 1986; 35(3): 221-32.
64. Chandrasekhar S, Sorrentino JA, Millis AJ. Interaction of fibronectin with collagen: age-specific defect in the biological activity of human fibroblast of fibronectin. Proc Natl Acad Sci U S A 1983; 80(15): 4747-51.
65. Porter MB, Pereira-Smith OM, Smith JR. Novel monoclonal antibodies identify antigenic determinats unique to cellular sencescience. J Cell Physiol 1990; 142(2): 425-33.
66. Ashcroft GS, Horan MA, Ferguson MW. Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a maurine incisional wound healing model. J Invest Dermatol 1997; 108 (4): 430-37.
67. Kligman AM, Lavker RM. Cutaneous aging: the differences between intrinsic aging photaging. J Cutan Aging & Cosm Dermatol 1998; 1(1): 5-12.
68. Uitto J, Fazio MJ, Olsen DR. Molecular mechanisms of cutaneos aging. Age-associated connective tissue alterations in the dermis. J Am Acad Dermatol 1989; 21(3 Pt 2): 614-22.
69. Lovell CR, Smolenski KA, Duance VC, Light ND, Young S, Dyson M, Type I and III collagen content and fibre distribution in normal human skin during ageing. Br J Dermatol 1987; 117(4): 419-28.
70. Fleischmajer R, Perlish JS, Bashey RI. Human dermal glycosaminoglycans and aging. Biochim Biophys Acta 1972; 279(2): 265-75.
71. Ashcroft GS, Horan MA, Herrick SE, Tarnuzzer RW, Schultz GS, Ferguson MW. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and route cutaneous wounds of healing humans. Cell Tissues Res 1997; 290(3): 581-91.
72. Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol 1997; 183(2): 169-76.
73. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001; 117(5): 1027-35.
74. Maier JA, Voulalas P, Roeder D, Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 1990; 249(4976): 1570-74.
75. Goodman L, Stein GH. Basal and induced amounts of interleukia-6 mRNA decline progressively wih age in human fibroblasts. J Biol Chem 1994; 269(30): 19250-55.